World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
92
Citations
33814
World Ranking
2200
National Ranking
1188

Medicine

D-Index
92
Citations
33704
World Ranking
11242
National Ranking
5772

Research.com Recognitions

  • 1982 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Henry C. Pitot was affiliated with the University of Wisconsin-Madison in the United States and contributed extensively to the field of medicine. Their research focused on several subfields, particularly oncology, pulmonary and respiratory medicine, surgery, pathology and forensic medicine, and molecular biology.

Their work spanned a variety of topics, including:

  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Esophageal Cancer Research and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers

Henry C. Pitot published frequently in the following venues:

  • Journal of Clinical Oncology
  • UNC Libraries
  • Clinical Cancer Research
  • Cancers
  • International Journal of Cancer

Some of their recent publications included:

  • "A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer" (2023, Journal of Clinical Oncology)
  • "Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction" (2022, Clinical Cancer Research)
  • "Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression" (2021, Cancers)
  • "Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma" (2021, International Journal of Cancer)
  • "Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan-based chemotherapy in patients with pancreas cancer" (2020, Pancreatology)

The scientist collaborated frequently with several co-authors, including:

  • Richard M. Goldberg
  • Harry H. Yoon
  • Qian Shi
  • Daniel J. Sargent
  • Zhaohui Jin

Henry C. Pitot was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 1982.

Best Publications

  • A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

    Richard M. Goldberg;Daniel J. Sargent;Roscoe F. Morton;Charles S. Fuchs

  • A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

    Amy Rapaich Moser;Henry C. Pitot;William F. Dove

  • Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations.

    G. Michalopoulos;H.C. Pitot

  • The stages of initiation and promotion in hepatocarcinogenesis.

    Henry C. Pitot;Alphonse E. Sirica

  • Pathology of mouse models of intestinal cancer: Consensus report and recommendations

    Gregory P. Boivin;Kay Washington;Kan Yang;Jerrold M. Ward

  • Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

    Jan Franko;Qian Shi;Charles D. Goldman;Barbara A. Pockaj

  • Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine

    Henry C. Pitot;Lona Barsness;Tom Goldsworthy;Tomoyuki Kitagawa

  • Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations.

    B. L. Kreamer;J. L. Staecker;N. Sawada;G. L. Sattler

  • Quantitative Evaluation of the Promotion by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of Hepatocarcinogenesis from Diethylnitrosamine

    Henry C. Pitot;Thomas Goldsworthy;H. A. Campbell;Alan Poland

  • Gamma-glutamyl transpeptidase--its role in hepatocarcinogenesis.

    Marie H. Hanigan;Henry C. Pitot

  • Phase II Study of Erlotinib in Patients With Advanced Biliary Cancer

    Philip A. Philip;Michelle R. Mahoney;Cristine Allmer;James Thomas

  • The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals

    Shiyu Song;Henry C. Pitot;Paul F. Lambert

  • Fetal phenotypic expression by adult rat hepatocytes on collagen gel/nylon meshes.

    Alphonse E. Sirica;William Richards;Yutaka Tsukada;Carol A. Sattler

  • Facts and theories concerning the mechanisms of carcinogenesis.

    Henry C. Pitot;Yvonne P. Dragan

  • Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

    Patrick A. Burch;Jami K. Breen;Jan C. Buckner;Dennis A. Gastineau

  • Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.

    Sam J. Lubner;Michelle R. Mahoney;Jill L. Kolesar;Noelle K. LoConte

  • Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial

    Richard M. Goldberg;Daniel J. Sargent;Roscoe F. Morton;Charles S. Fuchs

  • Application of Quantitative Stereology to the Evaluation of Enzymealtered Foci in Rat Liver

    H. A. Campbell;H. C. Pitot;Van R. Potter;B. A. Laishes

  • A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.

    Henry C. Pitot;Thomas L. Goldsworthy;Susan Moran;Wendy Kennan

  • The molecular biology of carcinogenesis.

    Henry C. Pitot

Frequent Co-Authors

Van R. Potter
Van R. Potter University of Wisconsin–Madison
Paul F. Lambert
Paul F. Lambert University of Wisconsin–Madison
Richard M. Goldberg
Richard M. Goldberg West Virginia University
George K. Michalopoulos
George K. Michalopoulos University of Pittsburgh
James A. Miller
James A. Miller University of Wisconsin–Madison
Harold P. Morris
Harold P. Morris Howard University
Philip A. Philip
Philip A. Philip Wayne State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Advancing your education in Biology or Biochemistry opens the door to many health science fields. For those seeking flexibility, many programs now exist fully online, allowing you to balance studies with other commitments. One entry point into healthcare is medical billing and coding, a role that plays a vital part in the management of medical records and healthcare information. If you’re wondering whether this field aligns with your goals, our guide on is medical billing and coding worth it covers the key advantages and challenges.

Those interested in more advanced study may explore options like a online master's degree in nutrition, which can lead to careers in dietetics, health education, or research. Similarly, earning an him degree online prepares you for managing electronic health records—an area in high demand as healthcare becomes increasingly digitized.

For those drawn to diagnostic imaging, sonography programs online offer training that can lead directly to clinical roles as ultrasound technicians. Carefully consider which online pathway supports your professional interests, personal strengths, and career ambitions in the life sciences.

Best Scientists Citing Henry C. Pitot